Literature DB >> 24285095

Decreased apopto-phagocytic gene expression in the macrophages of systemic lupus erythematosus patients.

G Majai1, E Kiss, T Tarr, G Zahuczky, Z Hartman, G Szegedi, L Fésüs.   

Abstract

The clearance of apoptotic cells has an important role in the maintenance of tissue homeostasis and in the protection of tissues from the inflammatory and immunogenic contents of dying cells. A defect in the recognition and phagocytosis of apoptotic cells contributes to the development of chronic inflammation and autoimmune disorders. We have observed that compared with healthy donors, differentiated macrophages from patients with untreated systemic lupus erythematosus (SLE) showed decreased phagocytosis of apoptotic neutrophils. A TaqMan Low Density Array was designed to determine the mRNA expression levels of 95 apopto-phagocytic genes in differentiated non-phagocytosing and phagocytosing macrophages. In the macrophages of clinically and immunoserologically active SLE patients, 39 genes were expressed at lower levels than in the control macrophages. When inactive patients were compared with those with minor immunoserological abnormalities or patients in an immunoserologically active state, a relationship was observed between the altered gene expression profile and the disease state. In the macrophages of patients with engulfing apoptotic cells, an upregulation of genes involved in inflammation, autophagy, and signaling was observed. These results indicate that novel immune-pathological pathways are involved in SLE and suggest targets for potential therapeutic modulation.

Entities:  

Keywords:  Lupus; apoptosis; autoimmunity; macrophage; phagocytosis

Mesh:

Substances:

Year:  2013        PMID: 24285095     DOI: 10.1177/0961203313511557

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  14 in total

1.  Podocytes and autophagy: a potential therapeutic target in lupus nephritis.

Authors:  Xu-Jie Zhou; Daniel J Klionsky; Hong Zhang
Journal:  Autophagy       Date:  2019-02-17       Impact factor: 16.016

Review 2.  C1q: A fresh look upon an old molecule.

Authors:  Nicole M Thielens; Francesco Tedesco; Suzanne S Bohlson; Christine Gaboriaud; Andrea J Tenner
Journal:  Mol Immunol       Date:  2017-06-07       Impact factor: 4.407

Review 3.  Innate Immune Dysregulation in the Development of Cardiovascular Disease in Lupus.

Authors:  Gantsetseg Tumurkhuu; Erica Montano; Caroline Jefferies
Journal:  Curr Rheumatol Rep       Date:  2019-07-23       Impact factor: 4.592

Review 4.  Novel insights into the role of inflammasomes in autoimmune and metabolic rheumatic diseases.

Authors:  Kleopatra Deuteraiou; George Kitas; Alexandros Garyfallos; Theodoros Dimitroulas
Journal:  Rheumatol Int       Date:  2018-06-04       Impact factor: 2.631

5.  Retinoid X receptor activation reverses age-related deficiencies in myelin debris phagocytosis and remyelination.

Authors:  Muktha S Natrajan; Alerie G de la Fuente; Abbe H Crawford; Eimear Linehan; Vanessa Nuñez; Kory R Johnson; Tianxia Wu; Denise C Fitzgerald; Mercedes Ricote; Bibiana Bielekova; Robin J M Franklin
Journal:  Brain       Date:  2015-10-12       Impact factor: 13.501

Review 6.  Manipulating autophagic processes in autoimmune diseases: a special focus on modulating chaperone-mediated autophagy, an emerging therapeutic target.

Authors:  Fengjuan Wang; Sylviane Muller
Journal:  Front Immunol       Date:  2015-05-19       Impact factor: 7.561

Review 7.  Contribution of Defective PS Recognition and Efferocytosis to Chronic Inflammation and Autoimmunity.

Authors:  Stanley Gititu Kimani; Ke Geng; Canan Kasikara; Sushil Kumar; Ganapathy Sriram; Yi Wu; Raymond B Birge
Journal:  Front Immunol       Date:  2014-11-10       Impact factor: 7.561

Review 8.  The role of macrophage polarization in infectious and inflammatory diseases.

Authors:  Adam C Labonte; Annie-Carole Tosello-Trampont; Young S Hahn
Journal:  Mol Cells       Date:  2014-03-12       Impact factor: 5.034

9.  Pioglitazone regulates myelin phagocytosis and multiple sclerosis monocytes.

Authors:  Muktha S Natrajan; Mika Komori; Peter Kosa; Kory R Johnson; Tianxia Wu; Robin J M Franklin; Bibiana Bielekova
Journal:  Ann Clin Transl Neurol       Date:  2015-10-27       Impact factor: 4.511

10.  Complement Component C1q Programs a Pro-Efferocytic Phenotype while Limiting TNFα Production in Primary Mouse and Human Macrophages.

Authors:  Holly J Hulsebus; Sean D O'Conner; Emily M Smith; Chunfa Jie; Suzanne S Bohlson
Journal:  Front Immunol       Date:  2016-06-15       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.